Medica Group
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Medica Group generated cash of $8,743,000, which is less than the previous year. Cash used in financing activities reached the amount of $312,000 last year. Net change in cash is therefore $1,388,000.
Cash Flow
| 2015 | 5.70M | -1.47M | -3.31M |
|---|---|---|---|
| 2016 | 6.78M | -1.21M | -2.94M |
| 2017 | 5.51M | -1.42M | -1.9M |
| 2018 | 9.63M | -1.59M | -2.36M |
| 2019 | 9.70M | -2.73M | -2.98M |
| 2020 | 8.64M | -15.74M | 4.46M |
| 2021 | 9.72M | -13.50M | -303K |
| 2022 | 8.74M | -7.83M | 312K |
MGP.L Cash Flow Statement (2015 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 9.61M | 13.93M | 16.57M | 12.58M | 6.90M | 4.71M | 2.08M | 1.16M |
Operating activities | ||||||||
Net income | 7.2M | 5.46M | 2.07M | 9.59M | 9.15M | 5.66M | 4.28M | 2.08M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||
Depreciation and amortization | 4.91M | 4.48M | 2.87M | 2.60M | 2.14M | 1.99M | 2.01M | 1.77M |
Stock-based compensation expense | 1.69M | 760K | 210K | 204K | 135K | 74K | 0 | 0 |
| Deferred income tax benefit | 1.69M | 760K | 210K | 204K | 135K | 74K | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | 8.74M | 9.72M | 8.64M | 9.70M | 9.63M | 5.51M | 6.78M | 5.70M |
Investing activities | ||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -2.90M | -2.07M | -2.00M | -2.82M | -1.64M | -1.43M | -1.22M | -1.48M |
Acquisitions Net | -4.93M | -11.42M | -13.81M | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -7.83M | -13.50M | -15.74M | -2.73M | -1.59M | -1.42M | -1.21M | -1.47M |
Financing activities | ||||||||
Common Stock Issued | 6K | 16.16M | 1K | 0 | 0 | 15M | 0 | 0 |
Payments for dividends | -3.32M | -3.16M | -945K | -2.61M | -2.05M | -611K | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -23.52M | -54K | 0 | 0 | 0 | -15.62M | 0 |
Cash used in financing activities | 312K | -303K | 4.46M | -2.98M | -2.36M | -1.9M | -2.94M | -3.31M |
Net Change In Cash | 1.38M | -4.31M | -2.64M | 3.98M | 5.68M | 2.19M | 2.62M | 924K |
Cash at end of period | 11.00M | 9.61M | 13.93M | 16.57M | 12.58M | 6.90M | 4.71M | 2.08M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |